Free Trial

Deprince Race & Zollo Inc. Has $43.67 Million Stock Holdings in Concentrix Co. (NASDAQ:CNXC)

Concentrix logo with Business Services background

Deprince Race & Zollo Inc. boosted its position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 55.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,009,133 shares of the company's stock after buying an additional 359,476 shares during the quarter. Deprince Race & Zollo Inc. owned approximately 1.57% of Concentrix worth $43,665,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nordea Investment Management AB raised its position in shares of Concentrix by 43.9% during the fourth quarter. Nordea Investment Management AB now owns 70,654 shares of the company's stock worth $3,076,000 after acquiring an additional 21,568 shares during the last quarter. Thompson Investment Management Inc. raised its holdings in Concentrix by 1,232.8% during the 4th quarter. Thompson Investment Management Inc. now owns 140,411 shares of the company's stock worth $6,076,000 after purchasing an additional 129,876 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Concentrix during the 4th quarter worth about $4,752,000. American Century Companies Inc. acquired a new position in Concentrix during the 4th quarter valued at about $539,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Concentrix in the 4th quarter valued at about $294,000. Institutional investors and hedge funds own 90.34% of the company's stock.

Concentrix Trading Down 1.6%

Concentrix stock traded down $0.90 during mid-day trading on Tuesday, hitting $54.76. 195,204 shares of the company's stock were exchanged, compared to its average volume of 700,721. The company's 50 day simple moving average is $49.05 and its 200-day simple moving average is $46.57. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $3.50 billion, a P/E ratio of 14.76, a PEG ratio of 0.63 and a beta of 0.52. Concentrix Co. has a fifty-two week low of $36.28 and a fifty-two week high of $77.00.

Concentrix (NASDAQ:CNXC - Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported $2.79 EPS for the quarter, topping analysts' consensus estimates of $2.58 by $0.21. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The company had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.37 billion. During the same quarter last year, the firm posted $2.57 earnings per share. Concentrix's revenue was down 1.3% compared to the same quarter last year. On average, equities analysts anticipate that Concentrix Co. will post 10.11 earnings per share for the current year.

Concentrix Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 6th. Shareholders of record on Friday, April 25th were issued a dividend of $0.3328 per share. This represents a $1.33 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date of this dividend was Friday, April 25th. Concentrix's dividend payout ratio (DPR) is presently 33.33%.

Analyst Upgrades and Downgrades

CNXC has been the topic of a number of recent research reports. Canaccord Genuity Group reduced their price objective on shares of Concentrix from $100.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. Barrington Research reduced their price target on Concentrix from $70.00 to $54.00 and set an "outperform" rating on the stock in a research report on Monday, March 24th. Finally, Bank of America lifted their price objective on Concentrix from $58.00 to $59.00 and gave the stock a "neutral" rating in a research note on Thursday, March 27th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $65.75.

Read Our Latest Stock Analysis on Concentrix

Insider Buying and Selling at Concentrix

In other news, CEO Christopher A. Caldwell purchased 1,000 shares of Concentrix stock in a transaction on Monday, April 21st. The stock was purchased at an average price of $46.00 per share, with a total value of $46,000.00. Following the transaction, the chief executive officer now directly owns 303,362 shares in the company, valued at $13,954,652. The trade was a 0.33% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Olivier Duha sold 29,444 shares of the firm's stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $48.52, for a total transaction of $1,428,622.88. Following the transaction, the director now directly owns 1,155,862 shares of the company's stock, valued at $56,082,424.24. This represents a 2.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,444 shares of company stock valued at $1,481,628 in the last 90 days. 3.20% of the stock is currently owned by company insiders.

About Concentrix

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Read More

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines